Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites

A 60-year-old woman with POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome and intractable ascites presented with acute renal failure and received hemodialysis (HD) therapy. Due to frequent intradialytic hypotension, ultrafiltration with cell-free...

Full description

Saved in:
Bibliographic Details
Main Authors: Hideyuki Hayasaka, Kiyonori Ito, Susumu Ookawara, Masaya Kofuji, Takayuki Uchida, Shunto Kawamura, Ayumi Gomyo, Haruhisa Miyazawa, Yuichiro Ueda, Keiji Hirai, Shun-ichi Kimura, Naoki Momose, Shinichi Kako, Yoshiyuki Morishita
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Nephrology
Online Access:http://dx.doi.org/10.1155/2022/7099227
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850221085386080256
author Hideyuki Hayasaka
Kiyonori Ito
Susumu Ookawara
Masaya Kofuji
Takayuki Uchida
Shunto Kawamura
Ayumi Gomyo
Haruhisa Miyazawa
Yuichiro Ueda
Keiji Hirai
Shun-ichi Kimura
Naoki Momose
Shinichi Kako
Yoshiyuki Morishita
author_facet Hideyuki Hayasaka
Kiyonori Ito
Susumu Ookawara
Masaya Kofuji
Takayuki Uchida
Shunto Kawamura
Ayumi Gomyo
Haruhisa Miyazawa
Yuichiro Ueda
Keiji Hirai
Shun-ichi Kimura
Naoki Momose
Shinichi Kako
Yoshiyuki Morishita
author_sort Hideyuki Hayasaka
collection DOAJ
description A 60-year-old woman with POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome and intractable ascites presented with acute renal failure and received hemodialysis (HD) therapy. Due to frequent intradialytic hypotension, ultrafiltration with cell-free and concentrated ascites reinfusion therapy (CART) was performed to adequately manage the body fluid status and massive ascites. During HD with CART, her blood pressure was maintained compared with that during HD without CART, and an ultrafiltration volume of 3.7 L was achieved after HD with CART. In HD patients with intradialytic hypotension and massive ascites, the combination of CART and ultrafiltration during HD may be an effective therapeutic option for body-fluid management.
format Article
id doaj-art-73f28be374b04a8f861add38ea3d87f6
institution OA Journals
issn 2090-665X
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Nephrology
spelling doaj-art-73f28be374b04a8f861add38ea3d87f62025-08-20T02:06:48ZengWileyCase Reports in Nephrology2090-665X2022-01-01202210.1155/2022/7099227Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable AscitesHideyuki Hayasaka0Kiyonori Ito1Susumu Ookawara2Masaya Kofuji3Takayuki Uchida4Shunto Kawamura5Ayumi Gomyo6Haruhisa Miyazawa7Yuichiro Ueda8Keiji Hirai9Shun-ichi Kimura10Naoki Momose11Shinichi Kako12Yoshiyuki Morishita13Department of Clinical EngineeringDivision of NephrologyDivision of NephrologyDepartment of Clinical EngineeringDepartment of Clinical EngineeringDivision of HematologyDivision of HematologyDivision of NephrologyDivision of NephrologyDivision of NephrologyDivision of HematologyDepartment of Clinical EngineeringDivision of HematologyDivision of NephrologyA 60-year-old woman with POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome and intractable ascites presented with acute renal failure and received hemodialysis (HD) therapy. Due to frequent intradialytic hypotension, ultrafiltration with cell-free and concentrated ascites reinfusion therapy (CART) was performed to adequately manage the body fluid status and massive ascites. During HD with CART, her blood pressure was maintained compared with that during HD without CART, and an ultrafiltration volume of 3.7 L was achieved after HD with CART. In HD patients with intradialytic hypotension and massive ascites, the combination of CART and ultrafiltration during HD may be an effective therapeutic option for body-fluid management.http://dx.doi.org/10.1155/2022/7099227
spellingShingle Hideyuki Hayasaka
Kiyonori Ito
Susumu Ookawara
Masaya Kofuji
Takayuki Uchida
Shunto Kawamura
Ayumi Gomyo
Haruhisa Miyazawa
Yuichiro Ueda
Keiji Hirai
Shun-ichi Kimura
Naoki Momose
Shinichi Kako
Yoshiyuki Morishita
Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites
Case Reports in Nephrology
title Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites
title_full Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites
title_fullStr Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites
title_full_unstemmed Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites
title_short Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites
title_sort cell free and concentrated ascites reinfusion therapy during hemodialysis for intradialytic hypotension and intractable ascites
url http://dx.doi.org/10.1155/2022/7099227
work_keys_str_mv AT hideyukihayasaka cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT kiyonoriito cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT susumuookawara cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT masayakofuji cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT takayukiuchida cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT shuntokawamura cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT ayumigomyo cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT haruhisamiyazawa cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT yuichiroueda cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT keijihirai cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT shunichikimura cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT naokimomose cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT shinichikako cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites
AT yoshiyukimorishita cellfreeandconcentratedascitesreinfusiontherapyduringhemodialysisforintradialytichypotensionandintractableascites